¥11.66 ($1.74)

+0.27 (+2.37%)

SHZ · Healthcare · Medical - Devices · Tech Score Neutral · Power 40 · ¥21.5B mcap · 1.14B float · 2.36% daily turnover

Revenue

$6.1B -23.5% ▼

5Y CAGR: -4.8%

Gross Profit

$3.5B -29.0% ▼

5Y CAGR: -8.8%

Operating Income

$253M -83.6% ▼

5Y CAGR: -33.6%

Net Income

$247M -80.4% ▼

5Y CAGR: -32.2%

EPS (Diluted)

$0.13 -80.4% ▼

5Y CAGR: -32.7%

EBITDA

$927M -54.6% ▼

5Y CAGR: -17.9%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$8.0B	$10.7B	$10.6B	$8.0B	$6.1B
YoY Growth	+3.1%	+32.6%	-0.5%	-24.8%	-23.5%
Cost of Revenue	$2.7B	$4.2B	$4.0B	$3.0B	$2.6B
Gross Profit	$5.4B	$6.5B	$6.6B	$5.0B	$3.5B
Gross Margin	66.9%	60.9%	62.1%	62.6%	58.1%
R&D Expenses	$736M	$908M	$957M	$879M	$770M
SG&A Expenses	$2.4B	$2.8B	$2.8B	$2.4B	$2.2B
Operating Expenses	$3.2B	$4.3B	$4.0B	$3.5B	$3.3B
Operating Income	$2.1B	$2.1B	$2.6B	$1.5B	$253M
Operating Margin	26.7%	20.1%	24.7%	19.4%	4.1%
Interest Expense	$284M	$237M	$197M	$176M	$185M
Income Before Tax	$2.2B	$2.1B	$2.6B	$1.6B	$226M
Tax Expense	$326M	$366M	$366M	$262M	$28M
Net Income	$1.8B	$1.7B	$2.2B	$1.3B	$247M
Net Margin	22.4%	16.1%	20.8%	15.8%	4.0%
EPS (Diluted)	$1.01	$0.95	$1.21	$0.68	$0.13
EBITDA	$2.5B	$3.0B	$3.2B	$2.0B	$927M
Shares Outstanding	1.78B	1.81B	1.82B	1.86B	1.85B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.4B	$1.3B	$1.7B	$1.6B	$1.6B	$1.5B	$1.7B	$1.5B
Cost of Revenue	$570M	$776M	$625M	$585M	$563M	$566M	$635M	$707M
Gross Profit	$832M	$542M	$1.1B	$1.0B	$1.0B	$978M	$1.0B	$835M
Gross Margin	59.4%	41.1%	64.0%	64.2%	64.1%	63.4%	62.0%	54.1%
R&D Expenses	$185M	$213M	$203M	$192M	$199M	$198M	$241M	$209M
SG&A Expenses	$499M	$741M	$437M	$413M	$434M	-$506M	$376M	$375M
Operating Expenses	$723M	$1.2B	$643M	$676M	$652M	$935M	$657M	$605M
Operating Income	$109M	-$658M	$468M	$372M	$354M	$44M	$381M	$230M
Operating Margin	7.8%	-49.9%	27.0%	22.8%	22.5%	2.8%	22.8%	14.9%
Interest Expense	$41M	$53M	$45M	$44M	$45M	$43M	$147M	$36M
Income Before Tax	$107M	-$677M	$465M	$364M	$330M	$57M	$259M	$226M
Tax Expense	$14M	-$91M	$88M	$42M	$34M	$34M	$36M	-$7M
Net Income	$105M	-$556M	$379M	$312M	$291M	-$20M	$247M	$253M
Net Margin	7.5%	-42.2%	21.8%	19.1%	18.6%	-1.3%	14.8%	16.4%
EPS (Diluted)	$0.06	$-0.30	$0.21	$0.17	$0.16	$-0.01	$0.13	$0.14
EBITDA	$291M	-$423M	$609M	$505M	$399M	$284M	$406M	$408M
Shares Outstanding	1.85B	1.85B	1.84B	1.84B	1.84B	1.84B	1.84B	1.84B

300003.SZ SHZ